Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05332392 · ClinicalTrials.gov registry record · NA
Clinical Performance of Masimo INVSENSOR00040
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT05332392 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 90 participants.
The verdict
NCT05332392, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
This study is designed to compare the accuracy of a noninvasive measurement of oxygen saturation and pulse rate to reference values obtained by a laboratory blood gas analyzer and a standard of care EKG monitor. Study procedures follow ISO-80601-2-61:2011 standard requirements for basic safety and essential performance of pulse oximeter equipment. Arterial blood samples will be collected from subjects while undergoing a controlled desaturation procedure wherein the concentration of oxygen inhaled is slowly reduced until the subject's arterial oxygen concentration is approximately 70%.
Interventions
- DEVICE INVSENSOR00040
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2022-04-14 |
| Est. Completion | 2023-04-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05332392
The ClinicalTrials.gov registry entry for NCT05332392 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which INVSENSOR00040 is the first listed.
NCT05332392 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05332392 about?
NCT05332392 is a clinical study titled "Clinical Performance of Masimo INVSENSOR00040". This study is designed to compare the accuracy of a noninvasive measurement of oxygen saturation and pulse rate to reference values obtained by a laboratory blood gas analyzer and a standard of care EKG monitor. Study procedures follow ISO-80601-2-61:2011 standard requirements for basic safety and ...
What is the current status of trial NCT05332392?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2022-04-14. Estimated completion is 2023-04-13.
What interventions are being tested in trial NCT05332392?
The interventions under investigation include: INVSENSOR00040 (DEVICE).
Who is sponsoring clinical trial NCT05332392?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.